Delivery Order SPE2DB24D3015-SPE2DB26FFWVG
- Not listed
- The Defense Logistics Agency (DLA) awarded a $9,609.57 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) under a firm fixed price contract type. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,018.19 to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of October 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract valued at $10,226.69. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $43,416.77 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, aligning with AmerisourceBergen's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) valued at $3,348.66 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 13, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count supply). This firm fixed-price delivery order, valued at $79,678.43, represents a non-competitive set-aside award and is scheduled for completion by August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,543.88 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) valued at $1,067.73 under a firm fixed price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-competitive delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office location, serving the federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) valued at $4,244.31 under a firm fixed-price contract type. The award was made on May 6, 2025, with an ultimate completion date of May 7, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,566.41 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units), with an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWVGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $7,496.49. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award was made without set-aside designation and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of November 3, 2025. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications and medical commodities to support military and veteran healthcare systems. CAPLYTA is an atypical antipsychotic used in psychiatric treatment, consistent with the company's portfolio of neurological and specialized therapeutic medications provided through the DLA Medical Supply Chain. This delivery order represents a routine pharmaceutical procurement under the comprehensive IDC vehicle that enables the company to fulfill diverse federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 10/31/25 |